- Home
- IVDA vs LIXT Comparison
IVDA vs LIXT Comparison
Compare IVDA & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- LIXT
- Stock Information
- Founded
- IVDA 2003
- LIXT 2005
- Country
- IVDA United States
- LIXT United States
- Employees
- IVDA N/A
- LIXT N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- LIXT Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- LIXT Health Care
- Exchange
- IVDA Nasdaq
- LIXT Nasdaq
- Market Cap
- IVDA 3.7M
- LIXT 4.2M
- IPO Year
- IVDA N/A
- LIXT N/A
- Fundamental
- Price
- IVDA $1.40
- LIXT $1.62
- Analyst Decision
- IVDA
- LIXT
- Analyst Count
- IVDA 0
- LIXT 0
- Target Price
- IVDA N/A
- LIXT N/A
- AVG Volume (30 Days)
- IVDA 213.5K
- LIXT 1.8M
- Earning Date
- IVDA 11-25-2024
- LIXT 11-12-2024
- Dividend Yield
- IVDA N/A
- LIXT N/A
- EPS Growth
- IVDA N/A
- LIXT N/A
- EPS
- IVDA N/A
- LIXT N/A
- Revenue
- IVDA $5,305,154.00
- LIXT N/A
- Revenue This Year
- IVDA $23.76
- LIXT N/A
- Revenue Next Year
- IVDA $229.89
- LIXT N/A
- P/E Ratio
- IVDA N/A
- LIXT N/A
- Revenue Growth
- IVDA N/A
- LIXT N/A
- 52 Week Low
- IVDA $1.27
- LIXT $1.31
- 52 Week High
- IVDA $10.16
- LIXT $4.42
- Technical
- Relative Strength Index (RSI)
- IVDA 43.18
- LIXT 43.04
- Support Level
- IVDA $1.27
- LIXT $1.56
- Resistance Level
- IVDA $1.56
- LIXT $1.87
- Average True Range (ATR)
- IVDA 0.22
- LIXT 0.23
- MACD
- IVDA 0.01
- LIXT -0.03
- Stochastic Oscillator
- IVDA 20.00
- LIXT 8.33
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.